TEXAS INSTRUMENTS PLANS TO INVEST MORE THAN $60 BILLION TO MANUFACTURE BILLIONS OF FOUNDATIONAL SEMICONDUCTORS IN THE U.S.

Leading U.S. companies Apple, Ford, Medtronic, NVIDIA and SpaceX strengthen partnerships with TI to unleash the next era of American innovation
DALLAS, TX – Texas Instruments (TI) (Nasdaq: TXN) announced its plans to invest more than $60 billion across seven U.S. semiconductor fabs, making this the largest investment in…

NVIDIA to Manufacture American-Made AI Supercomputers in U.S. for First Time

Tech Giant commits $500 Billion to Make Entirely in the U.S.
NVIDIA is working with its manufacturing partners to design and build factories that, for the first time, will produce NVIDIA AI supercomputers entirely in the U.S.

Together with leading manufacturing partners, the company has commissioned more than…

Metals Sector in St. Louis Region Thrives with $500 Million Investment

Workforce nears 16,000 and growing
St. Louis, MO – The St. Louis region ranks second in the United States for minerals and ores exports, primarily including metals and metal products. The availability of economically viable rare earth elements coupled with unparalleled transportation access and skilled workforce, is credited with attracting…

GE Aerospace to Invest Nearly $1B in U.S. Manufacturing in 2025

Investment in U.S. factories, supply chain nearly double from last year, with plans to hire 5,000 U.S. workers
Expansions, new inspection technology and building upgrades planned across more than two dozen communities

CINCINNATI, OH – GE Aerospace plans to invest nearly $1 billion in its U.S. factories…

Entos Pharmaceuticals Announces $198.5 Million Partnership with the Governments of Canada and Alberta to Accelerate Biomanufacturing of Fusogenix PLV Next Generation Therapeutics

This investment will help build a 103,000-square-foot R&D center and a GMP manufacturing facility in Edmonton, Alberta.
The biomanufacturing facility will develop and produce the Entos Fusogenix PLV drug delivery platform and the next generation of medicines.

EDMONTON, Alberta – Entos® Pharmaceuticals (Entos), a clinical-stage…